Our results indicate for the first time that terazosin significantly activates Pgk1-mediated protective defenses against gastrointestinal disease in an AKT- or Cas1/GSDMD-related pyroptosis manner. The gene discussed is GSDMD; the disease is gastrointestinal disease.